Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $364 | $272 | $734 | $1,226 |
| - Cash | $76 | $33 | $50 | $164 |
| + Debt | $25 | $25 | $25 | $25 |
| Enterprise Value | $313 | $264 | $710 | $1,088 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$47 | -$66 | -$58 | -$57 |
| % Margin | – | – | – | – |
| Net Income | -$50 | -$69 | -$61 | -$60 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.45 | -0.62 | -0.56 | -0.62 |
| % Growth | 27.4% | -10.7% | 9.7% | – |
| Operating Cash Flow | -$50 | -$49 | -$56 | -$47 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$50 | -$49 | -$56 | -$47 |